Drug recall · March 5, 2014
Gelnique recall
Why: Subpotent Drug: Drug potency was compromised during shipment.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Gelnique (oxybutynin chloride) Gel 10%, 100 mg in 1 g sachet, for topical use only. Physician sample in clamshell container with seven heat-sealed sachets. Rx Only. Watson Pharmaceuticals Inc, Corona, CA, 92890. NDC: 52544-084-77.
- Lots / codes
Lot #: 514656; Expiry: 03/14
- Quantity
- 38,227 Clamshells
- Company
- Actavis, Salt Lake City, UT
- Distribution
- Distributed nationwide to physicians as samples. No military/ govt/ VA or foreign consignees.
- Initiated
- February 7, 2014 · Voluntary: Firm initiated
- Classified
- February 25, 2014
- Reported
- March 5, 2014
- Ended
- September 5, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Oxybutynin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.